GLP Watchdog

Care Bare Rx vs Tomorrow

Neither Care Bare Rx nor Tomorrow has an FDA warning letter on record. On brand-name semaglutide pen, Care Bare Rx costs $11,928 less a year at standing rates: $705 a month against $1,699 a month at Tomorrow. It is one of two products the two sell at comparable terms.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Care Bare Rx / Tomorrow

Care Bare Rx logo

Care Bare Rx

9.0/10

Tomorrow logo

Tomorrow

7.1/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$199/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
All 50 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Care Bare RxFull review
Visit TomorrowFull review

Neither Care Bare Rx nor Tomorrow pays us. Links to them earn nothing. Scores: Care Bare Rx 9.0, Tomorrow 7.1. How we are paid

What the record shows

  1. 01

    Neither Care Bare Rx nor Tomorrow has an FDA warning letter on record.

  2. 02

    Care Bare Rx names four pharmacies. Tomorrow names no compounding pharmacy in our record.

  3. 03

    On brand-name semaglutide pen, Care Bare Rx costs $11,928 less a year at standing rates: $705 a month against $1,699 a month at Tomorrow. It is one of two products the two sell at comparable terms.

  4. 04

    Only Tomorrow lists a price for brand-name tirzepatide pen, compounded oral semaglutide and compounded oral tirzepatide.

  5. 05

    Care Bare Rx lists all 50 states. Tomorrow publishes no state list.

  6. 06

    Care Bare Rx does not state its cancellation terms; Tomorrow states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Care Bare Rx

Tomorrow

Compounded semaglutide injection

$199/mo

$2,388 a year

$199/mo

$2,388 a year

Compounded tirzepatide injection

$199/moLower

$2,388 a year

$299/mo

$3,588 a year

Brand-name semaglutide pen

$705/moLower

$8,460 a year

$1,699/mo

$20,388 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,399/mo

$16,788 a year

Compounded oral semaglutide
Not sold or not priced

$199/mo

$2,388 a year

Compounded oral tirzepatide
Not sold or not priced

$299/mo

$3,588 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Not stated
Yes, stated
Minimum term
Not stated
No contract. Plans renew monthly or every 3 months, as you choose, until canceled at least 3 days before the next billing date
Refunds
Not stated
"All prescription sales are final." "Charges already processed are non-refundable, and we do not refund partially used subscription periods."

Read off each seller’s own pages. Care Bare Rx: October 17, 2026. Tomorrow: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Care Bare Rx

9.0/10
  • $1,200 a year less on compounded tirzepatide injection
  • $11,928 a year less on brand-name semaglutide pen
  • Names its compounding pharmacy
Visit Care Bare Rx

The case for Tomorrow

7.1/10
  • Sells brand-name tirzepatide pen and compounded oral semaglutide, which Care Bare Rx does not price
  • States you can cancel at any time
  • Names no compounding pharmacy
  • Publishes no state list
Visit Tomorrow

Scores

Care Bare Rx 9.0 · Tomorrow 7.1 out of 10. Six weighted parts.

Value25%

8.8A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Care Bare Rx vs Tomorrow: questions

Neither Care Bare Rx nor Tomorrow has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Care Bare Rx names four pharmacies. Tomorrow names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Care Bare Rx, by $1,200 a year at standing rates. Care Bare Rx: $199 a month, about $2,388 a year. Tomorrow: $299 a month, about $3,588 a year.
Care Bare Rx does not state its cancellation terms. Tomorrow states you can cancel at any time; refunds: "all prescription sales are final." "charges already processed are non-refundable, and we do not refund partially used subscription periods.".
Neither Care Bare Rx nor Tomorrow pays us. Links to them earn nothing. Scores: Care Bare Rx 9.0, Tomorrow 7.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks